Abstract
Melasma is a common acquired disorder of symmetrical hyperpigmentation, classically manifested as brown patches on the face. It affects both genders but is primarily seen in women, particularly those with skin of color. Its etiology is unknown, but risk factors include genetic predisposition, ultraviolet light exposure, pregnancy, and exogenous hormones. Diagnosis is made clinically, aided by Wood’s lamp examination and absence of inflammation. Treatment is important, as melasma may be cosmetically disfiguring and chronic with significant effect on quality of life. Broad-spectrum sunscreen and topical depigmenting agents, such as triple combination therapy, can be efficacious in affected patients.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Sheth VM, Pandya AG. Melasma: a comprehensive update: part I. J Am Acad Dermatol. 2011;65(4):689–97; quiz 698.
Kimbrough-Green CK, Griffiths CE, Finkel LJ, Hamilton TA, Bulengo-Ransby SM, Ellis CN, Voorhees JJ. Topical retinoic acid (tretinoin) for melasma in black patients. Arch Dermatol. 1994;130(6):727–33.
Chan R, Park KC, Lee MH, Lee ES, Chang SE, Leow YH, Tay YK, Legarda-Montinola F, Tsai RY, Tsai TH, Shek S, Kerrouche N, Thomas G, Verallo-Rowell V. A randomized controlled trial of the efficacy and safety of a fixed triple combination (fluocinolone acetonide 0.01 %, hydroquinone 4 %, tretinoin 0.05 %) compared with hydroquinone 4 % cream in Asian patients with moderate to severe melasma. Br J Dermatol. 2008;159(3):697–703.
Bansal C, Naik H, Kar HK, Chauhan A. A comparison of low-fluence 1064-nm Q-switched Nd: YAG laser with topical 20 % azelaic acid cream and their combination in melasma in Indian patients. J Cutan Aesthet Surg. 2012;5(4):266–72.
Salem A, Gamil H, Ramadan A, Harras M, Amer A. Melasma: treatment evaluation. J Cosmet Laser Ther. 2009;11(3):146–50.
Farshi S. Comparative study of therapeutic effects of 20 % azelaic acid and hydroquinone 4 % cream in the treatment of melasma. J Cosmet Dermatol. 2011;10(4):282–7.
Lieu TJ, Pandya AG. Melasma quality of life measures. Dermatol Clin. 2012;30(2):269–80. viii.
Sheth VM, Pandya AG. Melasma: a comprehensive update: part II. J Am Acad Dermatol. 2011;65(4):699–714; quiz 715.
Estrada Castañón R, Andersson N. Community dermatology and the management of skin diseases in developing countries. Trop Doct. 1992;22 Suppl 1:3–6.
Rivas S, Pandya AG. Treatment of melasma with topical agents, peels and lasers: an evidence-based review. Am J Clin Dermatol. 2013;14(5):359–76.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Lieu, T.J., Pandya, A.G. (2014). Melasma. In: Jackson-Richards, D., Pandya, A. (eds) Dermatology Atlas for Skin of Color. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-54446-0_6
Download citation
DOI: https://doi.org/10.1007/978-3-642-54446-0_6
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-54445-3
Online ISBN: 978-3-642-54446-0
eBook Packages: MedicineMedicine (R0)